How does one prognosticate outcomes in pediatric primary sclerosing cholangitis? https://pubmed.ncbi.nlm.nih.gov/32464706/
Sindhu Pandurangi
Kayla Hartjes
https://jamanetwork.com/journals/jama/fullarticle/1866094
Alvin Chan
Pathophysiology and Natural History Primary sclerosing cholangitis (PSC) is a chronic, cholestatic liver disease, thought to be immune-mediated in nature, characterized by inflammation and fibrosis of...
Shruti Sakhuja
Efficacy and safety of maralixibat treatment in patients with Alagille syndrome and cholestatic pruritus (ICONIC): a randomised phase 2 study - ScienceDirect Continuing on with our spotlight on...
The Real Deal Behind Alagille Syndrome Background Alagille syndrome is an autosomal dominant, multisystem disorder with characteristic hepatic, cardiac, vascular, renal, skeletal, ocular, and facial...
Kanak Verma
A 39 year-old female was referred for an abnormal liver profile after she noted scleral icterus, fatigue, and pruritus. She denies alcohol, substance, herbal supplement, or recent antibiotic use. Labs...
Sarang Thaker
Brief Case Presentation A 17-year-old male with no significant past medical history presented with abdominal pain, diarrhea, vomiting, and elevated liver enzymes. His inflammatory markers were raised...
Ayesha Siddique
Primary sclerosing cholangitis (PSC) is a primary biliary disorder characterized by progressive destruction of bile ducts. In this post we will present the most classic microscopic findings of PSC...
Phoenix Bell
Primary biliary cholangitis (PBC) is a chronic liver disorder caused by progressive bile duct destruction. In this post, we will present the characteristic histologic findings of PBC, as well as the...
Is obeticholic acid effective in the treatment of patients with PBC?
Lizzie Aby
Enter your email here and receive monthly newsletters with new LFN material.
Registration failed. Please try again later.
